Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P00750 (
PLA
)
16,800
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The histological changes of
lichen sclerosus
suggest that significant remodelling of the extracellular matrix is occurring. As the proteases of the
plasminogen activator
system have been implicated in tissue remodelling, cell migration and tumour invasion, we performed an immunohistochemical study to look for evidence of alteration in the expression of plasminogen/plasmin, urokinase-type plasminogen activator,
tissue-type plasminogen activator
and alpha2-antiplasmin in biopsies of clinically typical vulval
lichen sclerosus
obtained from 11 untreated adult women. Normal vulva obtained from gynaecological procedures and samples of the patients' uninvolved thigh tissue were used as controls. No significant difference was seen in the staining pattern between the
lichen sclerosus
tissue and control tissue. However, although we found no immunohistochemical evidence that the
plasminogen activator
system is involved in the pathogenesis of vulval
lichen sclerosus
, it may be that other proteases are involved.
...
PMID:Do plasminogen activators play a role in lichen sclerosus? 1101 2